Fiducial

Flow Cytometry Market To Reach A Revised Size of USD 8.4 Billion By 2028, Growing At A CAGR of 8.7% | Valuates Reports

Retrieved on: 
Wednesday, October 12, 2022

- Global Flow Cytometry Reagents Market Insights, Forecast to 2028

Key Points: 
  • - Global Flow Cytometry Reagents Market Insights, Forecast to 2028
    - The global digital polymerase chain reaction market generated USD 508.8 million in 2020 and is projected to reach USD 1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.
  • - The global Hip Replacement market size is projected to reach USD 2688.1 million by 2028, from USD 2257.7 million in 2021, at a CAGR of 2.5% during 2022-2028.
  • - The global Orthopedic Devices market size is projected to reach USD 43250 million by 2027, from USD 34190 million in 2020, at a CAGR of 3.0% during 2021-2027.
  • - The global Biometrics market size is projected to reach USD 39030 million by 2028, from USD 15900 million in 2021, at a CAGR of 13.2% during 2022-2028.

Fiducial Markers Market Will Reach USD 131.4 Million By 2028 With A CAGR of 3.9% - Valuates Reports

Retrieved on: 
Thursday, March 31, 2022

The global fiducial markers market is expected to grow as cancer prevalence rises around the world.

Key Points: 
  • The global fiducial markers market is expected to grow as cancer prevalence rises around the world.
  • Fiducial markers market growth is expected to be fueled by factors such as oncologists' increased adoption of radiotherapy treatment and devices.
  • Based on the product, the metal-based markers segment is expected to be the most lucrative segment in the fiducial markers market.
  • Based on end-user, The hospital segment is expected to be the most lucrative segment in the fiducial markers market.

Fiducial Markers Market Will Reach USD 131.4 Million By 2028 With A CAGR of 3.9% - Valuates Reports

Retrieved on: 
Thursday, March 31, 2022

The global fiducial markers market is expected to grow as cancer prevalence rises around the world.

Key Points: 
  • The global fiducial markers market is expected to grow as cancer prevalence rises around the world.
  • Fiducial markers market growth is expected to be fueled by factors such as oncologists' increased adoption of radiotherapy treatment and devices.
  • Based on the product, the metal-based markers segment is expected to be the most lucrative segment in the fiducial markers market.
  • Based on end-user, The hospital segment is expected to be the most lucrative segment in the fiducial markers market.

Fiducial Markers Market, 2026

Retrieved on: 
Monday, March 29, 2021

Fiducial Markers Market is predicted to grow at a CAGR of 4.90% with a market value in 2026.

Key Points: 
  • Fiducial Markers Market is predicted to grow at a CAGR of 4.90% with a market value in 2026.
  • Fiducial markers are the tiny objects placed in or near a tumor to spot the area that needs to get surgery.
  • Fiducial markers based on the product is categorized into metal-based markers and other fiducial markers.
  • Metal-based markers are the most used markers in this process of radiotherapy, and the metal-based markers are further divided into pure gold, gold alloys, and other metal-based markers.

Fiducial Marker Sales Aided by Growing Preference for Image Guided Radiotherapy: Fact.MR

Retrieved on: 
Tuesday, February 2, 2021

Hence, efforts to bolster oncology research have registered an uptick, providing fertile ground for fiducial markers expansion .

Key Points: 
  • Hence, efforts to bolster oncology research have registered an uptick, providing fertile ground for fiducial markers expansion .
  • Over the years, fiducial markers have emerged as the gold standard for image guided radiotherapy, prompting manufacturers to introduce new products into the global market.
  • As governments in emerging countries bolster efforts to improve healthcare access, the scope for fiducial markers is poised to enhance in forthcoming years.
  • It consists of an adhesive-like iodine-based soft marker for adaptability to surrounding tissues, positional stability and visibility on relevant imaging modalities.

Fiducial Marker Sales Aided by Growing Preference for Image Guided Radiotherapy: Fact.MR

Retrieved on: 
Tuesday, February 2, 2021

Hence, efforts to bolster oncology research have registered an uptick, providing fertile ground for fiducial markers expansion .

Key Points: 
  • Hence, efforts to bolster oncology research have registered an uptick, providing fertile ground for fiducial markers expansion .
  • Over the years, fiducial markers have emerged as the gold standard for image guided radiotherapy, prompting manufacturers to introduce new products into the global market.
  • As governments in emerging countries bolster efforts to improve healthcare access, the scope for fiducial markers is poised to enhance in forthcoming years.
  • It consists of an adhesive-like iodine-based soft marker for adaptability to surrounding tissues, positional stability and visibility on relevant imaging modalities.

EnPro Announces Completion of Sale of GGB’s Bushing Block Business

Retrieved on: 
Tuesday, December 1, 2020

EnPro Industries, Inc. (NYSE: NPO), a leading technology company using materials science to push boundaries in semiconductor, life sciences, and other technology-enabled sectors, today announced that it has completed the sale of its GGB bushing block business located in Dieuze, France to Melma Group.

Key Points: 
  • EnPro Industries, Inc. (NYSE: NPO), a leading technology company using materials science to push boundaries in semiconductor, life sciences, and other technology-enabled sectors, today announced that it has completed the sale of its GGB bushing block business located in Dieuze, France to Melma Group.
  • EnPro communicated its intent to exit this business on June 18, 2020 and during the third quarter identified a buyer to purchase the business.
  • After announcing the exit of GGBs bushing block business in June, we are pleased to have received an offer from Melma Group to purchase and continue operating the business.
  • Oneida Associes served as exclusive transaction advisory firm to EnPro, and Fiducial Legal by Lamy served as legal counsel.

Fiducial Markers Market by Cancer Type, Product, End User, Modality - Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 18, 2020

The "Fiducial Markers Market by Cancer Type, Product, End User, Modality and Geography - Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Fiducial Markers Market by Cancer Type, Product, End User, Modality and Geography - Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.
  • Fiducial Markers Market is predicted to grow at a CAGR of 4.90% with a market value in 2026.
  • Fiducial markers based on the product is categorized into metal-based markers and other fiducial markers.
  • The ultrasound modality segment plays a major role on the basis of modality in the fiducial markers market.

Fiducial Markers Market To Reach USD 127.3 Million By 2027 | Reports And Data

Retrieved on: 
Monday, August 31, 2020

NEW YORK, Aug. 31, 2020 /PRNewswire/ -- The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data.

Key Points: 
  • NEW YORK, Aug. 31, 2020 /PRNewswire/ -- The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data.
  • The growing prevalence of cancer is a significant factor in driving the fiducial markers market growth.
  • By modalities, ultrasound is likely to grow at a rate of 4.7% over the forecast period for fiducial markers market.
  • For the purpose of this report, Reports and Data have segmented the global fiducial markers market on the basis of type, modalities, application, end-user, and region:

Fiducial Markers Market To Reach USD 127.3 Million By 2027 | Reports And Data

Retrieved on: 
Monday, August 31, 2020

- Market Size USD 90.6 Million in 2019, Market Growth - CAGR of 4.3%, Market Trends Increasing investment in cancer research

Key Points: 
  • - Market Size USD 90.6 Million in 2019, Market Growth - CAGR of 4.3%, Market Trends Increasing investment in cancer research
    NEW YORK, Aug. 31, 2020 /PRNewswire/ -- The global fiducial markers market is expected to reach USD 127.3 Million by 2027, according to a new report by Reports and Data.
  • The growing prevalence of cancer is a significant factor in driving the fiducial markers market growth.
  • By modalities, ultrasound is likely to grow at a rate of 4.7% over the forecast period for fiducial markers market.
  • For the purpose of this report, Reports and Data have segmented the global fiducial markers market on the basis of type, modalities, application, end-user, and region: